Correlation Between Novo Nordisk and Enzolytics
Can any of the company-specific risk be diversified away by investing in both Novo Nordisk and Enzolytics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novo Nordisk and Enzolytics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novo Nordisk AS and Enzolytics, you can compare the effects of market volatilities on Novo Nordisk and Enzolytics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novo Nordisk with a short position of Enzolytics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novo Nordisk and Enzolytics.
Diversification Opportunities for Novo Nordisk and Enzolytics
0.88 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Novo and Enzolytics is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding Novo Nordisk AS and Enzolytics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enzolytics and Novo Nordisk is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novo Nordisk AS are associated (or correlated) with Enzolytics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enzolytics has no effect on the direction of Novo Nordisk i.e., Novo Nordisk and Enzolytics go up and down completely randomly.
Pair Corralation between Novo Nordisk and Enzolytics
Considering the 90-day investment horizon Novo Nordisk AS is expected to generate 0.23 times more return on investment than Enzolytics. However, Novo Nordisk AS is 4.3 times less risky than Enzolytics. It trades about 0.06 of its potential returns per unit of risk. Enzolytics is currently generating about -0.05 per unit of risk. If you would invest 6,206 in Novo Nordisk AS on August 26, 2024 and sell it today you would earn a total of 4,300 from holding Novo Nordisk AS or generate 69.29% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Novo Nordisk AS vs. Enzolytics
Performance |
| Timeline |
| Novo Nordisk AS |
| Enzolytics |
Novo Nordisk and Enzolytics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Novo Nordisk and Enzolytics
The main advantage of trading using opposite Novo Nordisk and Enzolytics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novo Nordisk position performs unexpectedly, Enzolytics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enzolytics will offset losses from the drop in Enzolytics' long position.| Novo Nordisk vs. Regeneron Pharmaceuticals | Novo Nordisk vs. Crispr Therapeutics AG | Novo Nordisk vs. Sarepta Therapeutics | Novo Nordisk vs. Intellia Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |